A Study of ARRY-520 in Patients With Advanced Cancer

Clinical trial NCT00462358 · COMPLETED

Trial details

NCT number: NCT00462358
Sponsor: Array Biopharma, now a wholly owned subsidiary of Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2007-04-01
Primary completion: 2010-11-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.